ASH 2018 Caudia Stege HOVON 123

Caudia Stege PhD student, Amsterdam UMC, Amsterdam 


Geriatric Impairments and Low Muscle Mass Are Associated with Treatment Discontinuation and Overall Survival in Newly Diagnosed Non-Transplant Eligible Multiple Myeloma Patients (nte-NDMM) Treated with Dose-Adjusted Melphalan-Prednisone-Bortezomib (MPV) – Results of the Dutch HOVON 123 Study



Ask Speakers


Medical Information Request